DE60326003D1 - Ter verwendung des hepatozytenwachstumsfaktors - Google Patents

Ter verwendung des hepatozytenwachstumsfaktors

Info

Publication number
DE60326003D1
DE60326003D1 DE60326003T DE60326003T DE60326003D1 DE 60326003 D1 DE60326003 D1 DE 60326003D1 DE 60326003 T DE60326003 T DE 60326003T DE 60326003 T DE60326003 T DE 60326003T DE 60326003 D1 DE60326003 D1 DE 60326003D1
Authority
DE
Germany
Prior art keywords
growth factor
hepatocyte growth
hgf
ter use
culture medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60326003T
Other languages
English (en)
Inventor
Jouji Kokuzawa
Shinichi Yoshimura
Hideomi Kitajima
Jun Shinoda
Yasuhiko Kaku
Toru Iwama
Ryuichi Morishita
Takahiro Kunisada
Noboru Sakai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anges Inc
Original Assignee
Anges MG Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anges MG Inc filed Critical Anges MG Inc
Application granted granted Critical
Publication of DE60326003D1 publication Critical patent/DE60326003D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/12—Hepatocyte growth factor [HGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Psychology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60326003T 2002-12-02 2003-12-02 Ter verwendung des hepatozytenwachstumsfaktors Expired - Lifetime DE60326003D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43043102P 2002-12-02 2002-12-02
PCT/JP2003/015401 WO2004050865A1 (en) 2002-12-02 2003-12-02 Method for culturing neural stem cells using hepatocyte growth factor

Publications (1)

Publication Number Publication Date
DE60326003D1 true DE60326003D1 (de) 2009-03-12

Family

ID=32469472

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60326003T Expired - Lifetime DE60326003D1 (de) 2002-12-02 2003-12-02 Ter verwendung des hepatozytenwachstumsfaktors

Country Status (9)

Country Link
US (1) US20060134078A1 (de)
EP (1) EP1570052B1 (de)
JP (1) JP2006511214A (de)
CN (1) CN1745168A (de)
AT (1) ATE421575T1 (de)
AU (1) AU2003302707B2 (de)
CA (1) CA2507395A1 (de)
DE (1) DE60326003D1 (de)
WO (1) WO2004050865A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003273118B2 (en) * 2003-10-29 2007-05-17 Hyun-Soo Kim Method for differentiating mesenchymal stem cell into neural cell and pharmaceutical composition containing the neural cell for neurodegenerative disease
DK1758986T3 (en) 2004-06-09 2016-01-18 Univ Edinburgh Neural stem cells
JP4868199B2 (ja) * 2004-09-10 2012-02-01 学校法人鈴鹿医療科学大学 サルビアノール酸ｂを有効成分とする神経幹細胞増殖剤
US20070078083A1 (en) * 2005-09-07 2007-04-05 Braincells, Inc. MODULATION OF NEUORGENESIS BY HDac INHIBITION
US20110064700A1 (en) * 2007-06-27 2011-03-17 President And Fellows Of Harvard College Neural stem cells
US20100158878A1 (en) 2008-12-23 2010-06-24 Alexandra Capela Target populations of oligodendrocyte precursor cells and methods of making and using same
KR101446711B1 (ko) * 2011-05-23 2014-10-06 아주대학교산학협력단 간세포 성장인자 유전자 및 염기성 나선-고리-나선 계열의 신경형성 전사인자 유전자가 도입된 성체 줄기세포주 및 그의 용도
CN102399747B (zh) * 2011-11-24 2014-04-16 吉林省拓华生物科技有限公司 神经干细胞的传代分离方法
JP6981403B2 (ja) * 2016-03-31 2021-12-15 味の素株式会社 神経分化能を亢進させる神経幹細胞用培地

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753505A (en) * 1995-07-06 1998-05-19 Emory University Neuronal progenitor cells and uses thereof
US5968829A (en) * 1997-09-05 1999-10-19 Cytotherapeutics, Inc. Human CNS neural stem cells
US6184035B1 (en) * 1998-11-18 2001-02-06 California Institute Of Technology Methods for isolation and activation of, and control of differentiation from, skeletal muscle stem or progenitor cells
WO2000047238A1 (en) * 1999-02-11 2000-08-17 The Schepens Eye Research Institute, Inc. Integration of transplanted neural progenitor cells into neural tissue of immature and mature dystrophic recipients
KR100449141B1 (ko) * 2001-04-19 2004-09-21 (주)라이프코드 간엽 간세포를 신경세포로 분화시키는 방법

Also Published As

Publication number Publication date
EP1570052B1 (de) 2009-01-21
CA2507395A1 (en) 2004-06-17
AU2003302707A1 (en) 2004-06-23
AU2003302707B2 (en) 2008-10-02
CN1745168A (zh) 2006-03-08
ATE421575T1 (de) 2009-02-15
US20060134078A1 (en) 2006-06-22
JP2006511214A (ja) 2006-04-06
EP1570052A1 (de) 2005-09-07
WO2004050865A1 (en) 2004-06-17

Similar Documents

Publication Publication Date Title
ATE513901T1 (de) Neurale vorläuferzellen
DE60017875D1 (de) Verwendung von collagenase in der zubereitung von neuralen stammzellkulturen
DK0672162T3 (da) Forøget produktion af taxol og taxaner ved hjælp af cellekulturer af Taxus-arter
DE60326003D1 (de) Ter verwendung des hepatozytenwachstumsfaktors
ATE309369T1 (de) Heterologe herstellung von polyketiden
DE60236974D1 (de) Kultiviertes Zellkonstrukt mit Sphäroiden kultivierter Tierzellen und seine Verwendung
ATE346938T1 (de) Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen
DE50108487D1 (de) Bioreaktor für die kultivierung von mikroorganismen sowie verfahren zur herstellung desselben
ATE421994T1 (de) Genexpressionsmethode
HK1093755A1 (en) Method for differentiating mesenchymal stem cell into neural cell
ATE334188T1 (de) Zellkulturspinnerflaschen
WO1999067360A3 (en) Media and methods for expansion of erythroid stem cells for the production of hemoglobin
ATE393775T1 (de) Verfahren zur herstellung von aplidin und neue antitumoralen derivate, verfahren zu deren herstellung und zu deren verwendung
AR034815A1 (es) Produccion de celulas gliales radiales
DE69513186D1 (de) Photokatalysator, methode zur dessen herstellung, und erzeugung von wasserstoff unter verwendung des photokatalysators
TW200506058A (en) Method for culturing organic blue-green algae
ATE421574T1 (de) Zellkulturmethode zur erzeugung von prostata- ähnlichen acini
DE69940022D1 (de) Promotoren für wachstums-differenzierungsfaktoren und deren verwendung
TW200617165A (en) Process for preparing a conditioned medium of astrocyte-like cells
ATE391787T1 (de) Verfahren zur herstellung von ubiquinon-10
WO2002050301A3 (en) Gene expression profiles associated with osteoblast differentiation
ATE287981T1 (de) Herstellung von kohlenstofffasern mit hoher oberflächenenergie und hoher spezifischen oberfläche durch dampf-phase-pyrolise unter verwendung von kohlendioxid
DE69919989D1 (de) Verfahren zur herstellung transgener pflanzen unter verwendung von apikalspriessenspitzen
ATE310095T1 (de) Verfahren zur modulierung des niveaus von organischen schwefelverbindungen in pflanzen
ATE73847T1 (de) Dna-fragment mit dem cyclodextrin-glycosyltransferase-strukturgen, expressionsvektor, mikroorganismen zur expression und herstellungsverfahren.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition